VTGN | NASDAQ

Vistagen Therapeutics, Inc.

Vistagen Therapeutics, Inc. (VTGN) | runway 23.9 months | financing risk moderate | market cap $23.6M. Daily snapshot of financials, capital pressure, and re...

Company websiteLast updated Apr 29, 2026

Share price

$0.60

As of Apr 29, 2026

Market cap

$23.6M

Snapshot valuation

30D volume

761,283 shares

Rolling average daily volume

Runway

23.9 months

Estimated from precomputed burn and cash

Financing risk

N/A

Financing risk is present, but the current picture is not yet acute.

Snapshot summary

Runway: 23.9 months based on estimated burn.

Financing signal: Financing risk is present, but the current picture is not yet acute.

Latest development: Vistagen Therapeutics, Inc. 8-K 2026-04-28.

Recent developments

Vistagen Therapeutics, Inc. 8-K 2026-04-28

8-K filed on 2026-04-28.

Apr 27, 2026, 8:00 PM

Vistagen Therapeutics, Inc. 8-K 2026-04-13

8-K filed on 2026-04-13.

Apr 12, 2026, 8:00 PM

Vistagen Therapeutics, Inc. 8-K 2026-04-02

8-K filed on 2026-04-02.

Apr 1, 2026, 8:00 PM

Vistagen Therapeutics, Inc. 8-K 2026-03-18

8-K filed on 2026-03-18.

Mar 17, 2026, 8:00 PM

Vistagen Therapeutics, Inc. 8-K 2026-03-16

8-K filed on 2026-03-16.

Mar 15, 2026, 8:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures